H1N1 Test With Affymetrix Technology Gets FDA Approval

Date : 12/21/2009 @ 10:02AM
Source : Dow Jones News
Stock : Affymetrix, Inc. (delisted) (AFFX)
Quote : 14.01  0.0 (0.00%) @ 2:05AM

H1N1 Test With Affymetrix Technology Gets FDA Approval

Affymetrix (NASDAQ:AFFX)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Affymetrix Charts.

Affymetrix Inc. (AFFX) and TessArae LLC said the Food and Drug Administration has granted emergency use authorization for a H1N1 influenza detection panel.

Shares rose 9.6% premarket to $6.08. The stock has nearly doubled this year.

The product was created by privately held TessArae using technology from Affymetrix, which makes products to help analyze genetic information.

TessArae's product isn't the only one to receive such emergency clearance from the FDA for H1N1 detection, but the company said one of its product's unique aspects is that it "directly generates genomic sequence from multiple influenza virus genes" to identify the particular H1N1 virus strain in a single test.

 
   -By Kevin Kingsbury; Dow Jones Newswires; 212-416-2354; kevin.kingsbury@dowjones.com 
 
 
 



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.